和常规化疗不同的是，美罗华不导致血细胞减少或脱发。
Unlike regular chemotherapy, rituxan does not cause low blood counts or hair loss.
美罗华特异的识别和附着于在一些淋巴细胞表面可以找到蛋白cd 20。
Rituximab specifically recognizes and attaches to a protein called CD20 that is found on the surface of some lymphocytes.
患者可在肿瘤专家的办公室或门诊接受静脉注入美罗华。
Patients get rituximab through infusion into a vein (IV) at the oncologist's office or clinic.
观察等待是无症状的晚期滤泡性淋巴瘤常用的策略，但是对于这些患者来说美罗华单药治疗也是一个选项。
Watch and wait (WAW) is a common approach for asymptomatic, advanced stage follicular lymphoma (FL), but single-agent rituximab is an alternative for these patients.
许美珍，罗来树，李颐，吴延庆，姜醒华，徐劲松血管内超声与冠状动脉造影在冠状动脉支架置入中的应用比较。
Xu M. -z., Luo L. -s., Li Y., Wu Y. -q., Jiang X. -h., Xu J. -s. Intravascular ultrasound versus coronary angiography in coronary artery stent implantation.
美罗华可有效地控制麦当劳中的一个子集的患者。
Rituximab may be effective in controlling MCD in a subset of patients.
我们观察到的恶化伴随皮肤卡波西氏肉瘤，并推测这种美罗华可能加剧。
We observed an aggravation of concomitant cutaneous Kaposi sarcoma, and hypothesize that rituximab could have exacerbated it.
我们成功的治疗报告，并与血浆中的美罗华吗啉抗体阴性复发疾病。
We report successful treatment with plasmapheresis and rituximab in NMO-IgG-negative relapsing disease.
的确，鉴于四大方面存在不确定性，我预计有些二线事务所，比如致同、德豪国际、国富浩华和罗申美，将承接一系列IPO工作。
I do expect that some of the second-tier firms like Grant Thornton, BDO, and Crowe Horwath/RSM are going to pick up a number of IPOs given the uncertainty surrounding the Big Four.
交替半身照射联合美罗华治疗弥漫性大B细胞淋巴瘤有明显的增效、减毒及改善患者生活质量的作用。
The project of alternate half-body irradiation combined with R-CHOP to treat DLBCL has effect on apparente synergia and attenuation and could improve the patient's quality of life.
添加GM-CSF不减弱美罗华的耐受性，不良反应很少，并且很轻。
Addition of GM-CSF did not impair tolerance to rituximab, and adverse events were rare and mild.
美罗华可有效地用于治疗抗cd 20阳性毫米。
Rituximab may be effective for the treatment of CD20-positive MM.
结论美罗华治疗老年aiha患者安全、有效。
Conclusion Mabthera was safe and effective for the treatment of elderly patients with AIHA.
目的探讨抗肿瘤靶向药物利妥昔单抗（美罗华）不良反应的特点及规律，为临床安全、合理用药提供参考。
Objective To investigate the adverse reactions of rituximab (Rituxan and MabThera) in retrospection to provide references for safe and rational drug use clinically.
美罗华在体外对上述两种细胞系有轻度的增殖抑制作用，但促凋亡并不明显。
However, it could enhance the anti-proliferation and apoptosis inducing effect of CS055 on MCL cells when combined with CS055.
美罗华在体外对上述两种细胞系有轻度的增殖抑制作用，但促凋亡并不明显。
However, it could enhance the anti-proliferation and apoptosis inducing effect of CS055 on MCL cells when combined with CS055.
应用推荐